The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intense exercise for survival among men with metastatic prostate cancer: 12 months feasibility results from the INTERVAL-GAP4 trial.
 
Robert Usher Newton
No Relationships to Disclose
 
Pedro Lopez
No Relationships to Disclose
 
Nicolas H. Hart
Research Funding - GenesisCare (Inst); Ipsen Pharmaceutical Pty Ltd; Pernix Pty Ltd (Inst)
 
Daniel Abido Galvao
No Relationships to Disclose
 
Dennis R Taaffe
No Relationships to Disclose
 
Timothy Dudley Clay
Stock and Other Ownership Interests - ClinicIQ
Honoraria - Lilly; Specialised Therapeutics; Wiley
Consulting or Advisory Role - AstraZeneca/MedImmune; Cipla; Foundation Medicine; Merck KGaA; Takeda
Speakers' Bureau - AstraZeneca/MedImmune; MSD
Research Funding - Abbvie (Inst); Amgen (Inst); Bayer (Inst); BeiGene (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Immutep (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Charles M Ryan
No Relationships to Disclose
 
Stacey A. Kenfield
Leadership - Fellow Health Partners
Stock and Other Ownership Interests - Fellow Health Partners
Consulting or Advisory Role - Fellow Health Partners
Research Funding - GenomeDx
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)